Research may pave the way for systemic targeted therapy for patients with pseudomyxoma peritonei

FHS
July 20, 2024
12:19 am

Published in Clinical Cancer Research, results of a preclinical study led by investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Stem Cells and Cancer Group, headed by Héctor G. Palmer, pave the way for systemic targeted therapy in patients with pseudomyxoma peritonei, a rare form of cancer with very few therapeutic options available.

UK rejoins EU’s Horizon Europe science programme – Pharmaceutical Technology

The UK has rejoined EU’s Horizon Europe science research programme. Image Credit: Shutterstock / vlastas The UK has re-joined the EU’s Horizon Europe science research

September 7, 2023

Study describes the scope and integration of music therapy program within UH medical centers

A new study from University Hospitals (UH) Connor Whole Health describes the scope and integration of their music therapy program within10 UH medical centers.

July 15, 2023

Ovary removal before menopause could accelerate brain degeneration

Premenopausal bilateral oophorectomy (PBO) is linked to reduced white matter integrity in the brain, particularly in women who undergo PBO before the age of 40,

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.